12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
週二盤前交易時段，12只醫療保健股走勢
Gainers
獲勝者
- Regulus Therapeutics (NASDAQ:RGLS) stock moved upwards by 84.8% to $2.55 during Tuesday's pre-market session. The company's market cap stands at $51.5 million.
- Assure Hldgs (NASDAQ:IONM) stock increased by 73.02% to $0.59. The market value of their outstanding shares is at $3.9 million.
- Telomir Pharmaceuticals (NASDAQ:TELO) shares increased by 24.89% to $8.58. The market value of their outstanding shares is at $262.6 million.
- Bioventus (NASDAQ:BVS) shares increased by 16.0% to $6.16. The market value of their outstanding shares is at $387.8 million. The company's, Q4 earnings came out today.
- Genelux (NASDAQ:GNLX) stock increased by 14.79% to $7.45. The company's market cap stands at $199.0 million.
- Kineta (NASDAQ:KA) stock moved upwards by 14.37% to $0.79. The company's market cap stands at $8.2 million.
- 在週二的盤前交易中，Regulus Therapeutics（納斯達克股票代碼：RGLS）股價上漲了84.8％，至2.55美元。該公司的市值爲5150萬美元。
- Assure Hldgs（納斯達克股票代碼：IONM）的股票上漲了73.02％，至0.59美元。他們已發行股票的市值爲390萬美元。
- Telomir Pharmicals（納斯達克股票代碼：TELO）股價上漲24.89％，至8.58美元。他們已發行股票的市值爲2.626億美元。
- Bioventus（納斯達克股票代碼：BVS）股價上漲16.0％，至6.16美元。他們已發行股票的市值爲3.878億美元。該公司今天公佈了第四季度的收益。
- Genelux（納斯達克股票代碼：GNLX）股價上漲14.79％，至7.45美元。該公司的市值爲1.99億美元。
- Kineta（納斯達克股票代碼：KA）股價上漲14.37％，至0.79美元。該公司的市值爲820萬美元。
Losers
失敗者
- Renalytix (NASDAQ:RNLX) shares fell 27.2% to $0.83 during Tuesday's pre-market session. The market value of their outstanding shares is at $41.4 million.
- CytomX Therapeutics (NASDAQ:CTMX) stock declined by 17.63% to $2.07. The company's market cap stands at $138.5 million. As per the press release, Q4 earnings came out yesterday.
- Psyence Biomedical (NASDAQ:PBM) shares fell 17.52% to $1.46. The market value of their outstanding shares is at $19.5 million.
- ACADIA Pharmaceuticals (NASDAQ:ACAD) stock fell 16.46% to $20.16. The market value of their outstanding shares is at $3.3 billion.
- NRX Pharmaceuticals (NASDAQ:NRXP) stock declined by 16.3% to $0.56. The market value of their outstanding shares is at $51.3 million.
- Finch Therapeutics Gr (NASDAQ:FNCH) shares fell 13.7% to $2.95. The company's market cap stands at $4.7 million.
- 在週二的盤前交易中，Renalytix（納斯達克股票代碼：RNLX）股價下跌27.2％，至0.83美元。他們已發行股票的市值爲4140萬美元。
- CytomX Therapeutics（納斯達克股票代碼：CTMX）股價下跌17.63％，至2.07美元。該公司的市值爲1.385億美元。根據新聞稿，第四季度業績於昨天公佈。
- Psyence Biomedical（納斯達克股票代碼：PBM）股價下跌17.52％，至1.46美元。他們已發行股票的市值爲1,950萬美元。
- 阿卡迪亞製藥公司（納斯達克股票代碼：ACAD）股價下跌16.46％，至20.16美元。他們已發行股票的市值爲33億美元。
- NRX製藥公司（納斯達克股票代碼：NRXP）股價下跌16.3％，至0.56美元。他們已發行股票的市值爲5,130萬美元。
- Finch Therapeutics Gr（納斯達克股票代碼：FNCH）股價下跌13.7％，至2.95美元。該公司的市值爲470萬美元。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。